MPMaría Belén Pisano

María Belén Pisano

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


María Belén Pisano has a total of 190 co-authors. Here are the top co-authors by number of shared publications:

  • Viviana E. Ré

    Instituto de Virología "Dr. J. M. Vanella", CONICET, Facultad de Ciencias Médicas, Universidad Nacional de Córdoba, Enfermera Gordillo Gómez s/n, Ciudad Universitaria, CP, 5016, Córdoba, Argentina

    12 shared publications
  • Paola Sicilia

    Gobierno de la Provincia de Córdoba. Ministerio de Producción Ciencia e Innovación Tecnológica. Laboratorio Central

    10 shared publications
  • María Gabriela Barbás

    Departamento Laboratorio Central de la Provincia de Córdoba, Córdoba, Argentina

    7 shared publications
  • Gonzalo M. Castro

    Gobierno de la Provincia de Córdoba. Ministerio de Producción Ciencia e Innovación Tecnológica. Laboratorio Central

    6 shared publications
  • Guadalupe Di Cola

    Instituto de Virología “Dr. J. M. Vanella”, CONICET, Facultad de Ciencias Médicas, Universidad Nacional de Córdoba, Córdoba, Argentina

    5 shared publications
  • Laura López

    Ministerio de Salud de la Provincia de Córdoba

    5 shared publications

Latest Publications

  • First Detection of Hepatitis E Virus in Wastewater in Costa Rica

    by Bradd Mendoza-Guido, Taimy Calvo, Luis Chacón, María Belén Pisano, Gisela Masachessi, Luz Chacón

    Hepatitis E virus (HEV) is an important cause of acute viral hepatitis worldwide, with both human-restricted (genotypes 1 and 2) and zoonotic lineages (genotypes 3 and 4). However, information regarding HEV circulation in Central America remains limited. In this study, wastewater-based epidemiological surveillance was conducted in San José, Costa Rica, during 2025 to investigate the presence of HEV in the main wastewater treatment plant serving approximately one million inhabitants. A total of 54 influent and effluent samples were analyzed. HEV RNA was not detected by quantitative RT-PCR; however, RT-nested PCR targeting the ORF1 region identified three positive influent samples. Sequencing yielded two high-quality partial ORF1 sequences suitable for phylogenetic analysis. Both Costa Rican sequences clustered together and showed a close relationship to genotype 3 sequences. To our knowledge, this represents the first report of HEV detected in wastewater in Costa Rica and the first scientific report of environmental detection in Central America. These findings highlight the value of wastewater-based surveillance for identifying circulating viral pathogens in regions where routine clinical testing is limited.

  • Open Access

    Evidence of Wild Boars as a Reservoir of Zoonotic Hepatitis E Virus Genotype 3: Implications for Public Health in Argentina

    by Macarena Marta Williman, Santiago Emanuel Colina, Guadalupe Di Cola, Diana Sofia Ozaeta, Bruno Nicolás Carpinetti, María Belén Pisano, Viviana Elizabeth Ré, María Soledad Serena, María Gabriela Echeverría, Germán Ernesto Metz

    Hepatitis E virus (HEV) is a global public health concern, causing over 20 million infections annually. It is primarily transmitted via the fecal–oral route, with wild boars and domestic swine as major reservoirs involved in zoonotic transmission. Bahía de Samborombón is an important natural reserve in Argentina characterized by a high population of wild boars, located in a livestock-intensive region near major urban centers. As part of a wild boar control program, 11 sampling campaigns were carried out between 2022 and 2023. Fecal, blood, and liver samples were systematically collected from 80 captured animals for the detection and characterization of HEV through antibody and RNA testing. Serological analysis revealed a positivity rate of 42.4%, whereas RT-qPCR detected HEV RNA in 9.1% of fecal samples and 12.5% of liver samples. From the positive samples, seven viral sequences were recovered using RT-nested PCR, including six from ORF1 and one from ORF2. Phylogenetic analysis clustered these sequences within zoonotic HEV genotype 3, showing a close relationship with human sequences from Buenos Aires and neighboring provinces. This study confirms the presence of HEV in wild boars from Argentina, highlighting the circulation of genotype 3, clade abchijklmno and the associated zoonotic risk.


  • Open Access

    Hepatitis E Virus Infection in Patients With Chronic Liver Diseases: A Latin American Multicenter Study

    by Anabella Clara Fantilli, María Belén Pisano, Maribel Martínez Wassaf, Guadalupe Di Cola, Domingo Balderramo, Pablo Romagnoli, Jhon Prieto, Marco Arrese, Enrique Carrera, Javier Díaz Ferrer, et al.

    Background: Hepatitis E virus (HEV) is a major cause of acute hepatitis worldwide, yet its impact in Latin America remains underexplored. Evidence suggests that chronic liver disease (CLD) patients infected with HEV face increased risks of disease progression and mortality. The PROGINS haplotype has been proposed to influence susceptibility to HEV. This study assessed HEV infection in CLD patients from Latin America and potential associated factors, including the PROGINS haplotype. Methods: A total of 971 individuals—784 with CLD and 187 healthy controls (HC)—from six countries (Argentina, Brazil, Chile, Colombia, Ecuador, and Peru) were analyzed for anti-HEV IgG and IgM (ELISA), HEV-RNA (RT-qPCR and nested PCR with Sanger sequencing and phylogenetic analysis), and the PROGINS haplotype (PCR). Results: The overall anti-HEV IgG seroprevalence was 15.2%: 15.4% in CLD and 14.4% in HC, with no statistical difference. Marked geographical disparities were observed, with Chile showing the highest (45.1%) and Argentina the lowest (4.2%) anti-HEV IgG detection rates. Cirrhosis and alcohol-related liver disease (ALD) were significantly associated with higher detection rates, while neither age nor sex influenced HEV seroprevalences. PROGINS haplotype showed no significant association with HEV infection. Anti-HEV IgM and HEV-RNA were detected in 11.2% and 0.4% of participants, respectively. Phylogenetic analysis confirmed zoonotic HEV-3 circulation in the region. Conclusions: This first multinational assessment of HEV in Latin America reveals heterogeneous seroprevalence across countries. Findings support considering HEV testing in diagnostic protocols for CLD patients particularly those with cirrhosis or ALD- when presenting with unexplained hepatic decompensation or acute hepatitis.

  • Open Access

    Circulación del SARS-CoV-2 en embarazadas del centro de Argentina

    by Leticia D´aUgero, Gonzalo M. Castro, Paola Sicilia, Eugenio Cecchetto, Laura Lopez, Graciela Scruzzi, Paula Barbero, Maria del Pilar Diaz, Maria Gabriela Babas, Viviana Re, et al.

    Introduction: SARS-CoV-2 can lead to a more severe infection during pregnancy. However, population-level data on COVID-19 disease and vaccine uptake in this population group are lacking, especially in South America. Objective:We aimed to describe SARS-CoV-2 infection in pregnant women from a central region of Argentina. Methodology:From March-2020 to March-2022, 2407 cases of pregnant women from Córdoba province with confirmed SARS-CoV-2 infection reported in the official records were analyzed. The infectivity and mortality rates were calculated; a control group of non-pregnant women infected with SARS-CoV-2 was included. Sixty-six samples were subjected to variants of concern (VOC) detection by real time RT-PCR. Results:The overall infection rate was 0.25%, and the number of infections mirrored the number of cases for general population. In September-2021 (when mass vaccination in pregnant women occurred) the infection rate decreased (0.35% in March 2020-September 2021 vs. 0.14% in October 2021-March 2022). The global fatality rate was 0.75% (18/2407). During March-2020 to September-2021 the fatality rate was higher than in the control group: 1.01% vs. 0.08% (p<0.05). Since then, no deaths were recorded in pregnant women (fatality rate 0% vs. 0.01% in the control group). The VOCs distribution was: Gamma: 56%, Delta: 20%, Omicron: 12%, Alpha: 3%, 9% of non-VOC lineages.Conclusions:The fatality rate found was similar to that obtained for the entire country in this group, and higher than the control group. The frequency of VOCs reflected what happened in the general population. The decrease in cases and deaths since September-2021 correlated with the mass vaccination in this group.

  • Open Access

    Novel strategy for whole-genome sequencing of hepatitis A virus using NGS illumina technology and phylogenetic comparison with partial VP1/2A genomic region

    by Paola Sicilia, Anabella Clara Fantilli, Facundo Cuba, Guadalupe Di Cola, María Gabriela Barbás, Tomás Poklepovich, Viviana Elizabeth Ré, Gonzalo Castro, María Belén Pisano

    Molecular epidemiology of hepatitis A virus (HAV) plays a critical role in identifying outbreak origin and conducting surveillance. Although it is mostly carried out using short partial VP1/2A genomic sequences, utilizing whole-genome sequences (WGS) provides more accurate and robust information. We developed an amplicon-based next-generation sequencing (NGS) strategy to obtain complete HAV genomes utilizing the COVIDSeq Test (Illumina). Twenty-five primer pairs were designed and used to amplify partial genomic fragments (400 bp) that comprise the entire HAV genome sequence from previously HAV positive serum and stool samples from Argentina. The DNA library was prepared using the Illumina COVIDSeq Test and sequenced in a MiSeq equipment. Phylogenetic analyses were performed with IQ-Tree using WGS and VP1/2A partial sequences of 1084pb and 422pb. Eleven samples were amplified and sequenced, with coverage between 79.3 and 100% (> 90% in 9 samples). Although phylogenetic analyses of partial sequences allowed genotype and subgenotype identification, WGS analyses yielded more accurate and reliable results for the phylogeny (phylogenetic definition). The amplicon-based NGS WGS tool developed by adapting the COVIDSeq test to HAV proved to be efficient. The study of partial VP1/2A regions (mainly the 1084 bp fragment) would constitute useful alternatives for outbreak investigation and surveillance when WGS could not be performed.


  • Open Access

    Hepatitis A in central Argentina: anti-HAV prevalence in adults living in a region of low endemicity after 17 years of the official introduction of the vaccine.

    by Gonzalo Castro, Vanesa Mamani, Jorge Mariojoules Bringas, Pablo Chumacero, Paola Díaz, Graciela Scruzzi, Maribel Martínez Wassaf, Mariel Borda, Laura López, Maria Barbas, et al.

    Hepatitis A virus (HAV) has a low endemic circulation pattern in Argentina. Notifications of clinical cases occur especially in susceptible young adults in whom outbreaks have recently been reported. The aim of this study was to provide updated information on HAV immune status of the adult population from central Argentina. A retrospective analysis was carried out recording the results of IgG-anti HAV in 4235 samples of people without prior vaccination from Córdoba, Argentina (2019 and 2022). Epidemiological data was recorded: sex, age, HIV status, income-status. The overall prevalence of anti-HAV was 70.1%. It increased with age, was associated with the low-income population and was significantly higher in female patients (p<0.0001). Individuals under 35 years old exhibited anti-HAV IgG rates 18 years old in our region. In case they are negative, it is recommended vaccination.

  • Open Access

    Hepatitis E virus in children and adolescents living in an urban environment in central Argentina: An explorative study

    by Lorena L. Cervella, Cecilia García Oro, Anabella C. Fantilli, Guadalupe Di Cola, Maribel G. Martínez Wassaf, Gabriela Oropeza, Gonzalo M. Castro, Paola Sicilia, Viviana E. Ré, Maria Belén Pisano


  • Open Access

    Hepatitis A virus whole genome sequencing strategy using NGS/Illumina technology

    by Paola Sicilia, Anabella C. Fantilli, Facundo Cuba, Guadalupe Di Cola, María Gabriela Barbás, Tomás Poklepovich, Viviana E. Ré, Gonzalo Castro, María Belén Pisano

    Background Molecular epidemiology of hepatitis A virus (HAV) plays a critical role in identifying outbreak origin and conducting surveillance. Although it is mostly carried out using short partial VP1/2A genomic sequences, utilizing whole-genome sequences (WGS) provides more accurate and robust information. Objective we aimed to develop an amplicon-based next-generation sequencing (NGS) strategy to obtain complete HAV genomes utilizing the COVIDSeq Test (Illumina), available in surveillance laboratories after the COVID19 pandemic. Study design 25 primer pairs were designed and used to amplify partial genomic fragments (400bp) that comprise the entire HAV genome sequence from HAV previously positive serum and stool samples from Argentina. The DNA library was prepared using the Illumina COVIDSeq Test and sequenced in a MiSeq equipment. Phylogenetic analyses were performed with IQ-Tree using WGS and VP1/2A partial sequences of 1084pb and 422pb. Results 11 samples could be successfully amplified and sequenced, with horizontal coverage between 79.3%-100% (>90% in 9 samples). Individual RT-PCRs and Sanger sequencing with specific primers had to be performed in 6 samples to cover gaps of Ns. Phylogenetic analyses of WGS and VP1/2A partial sequences yielded similar results (clustering with genotype IA), although 422pb fragments showed low accurate grouping definition. Conclusion the amplicon-based NGS whole genome sequencing tool developed by adapting the COVIDSeq test to HAV, proved to be efficient in generating new complete and near-complete viral sequences. The study of the 1084bp fragment of the VP1/2A region would constitute a useful alternative option for outbreak investigation with public health impact.


  • Open Access

    Molecular detection of SARS-CoV-2 in Argentina: Evaluation of alternative diagnostic tools for the decentralization of the diagnosis

    by Gonzalo Manuel Castro, Paola Sicilia, Robertino Gierotto, Julieta Sosa, Andrés Marcos Castellaro, María Gabriela Barbás, María Belén Pisano, Viviana E. Ré

  • Open Access

    Reply to comment on “Hepatitis E virus in blood donors from Argentina: A possible source of viral infection?"

    by María Belén Pisano, Sebastián Blanco, Guadalupe Di Cola, Anabella C. Fantilli, Maribel Graciela Martínez Wassaf, Luis H. Carrizo, Viviana E. Ré, Sandra V. Gallego